A national cancer clinical trials system for the 21st century: reinvigorating the NCI Cooperative Group Program.

@article{Scoggins2010ANC,
  title={A national cancer clinical trials system for the 21st century: reinvigorating the NCI Cooperative Group Program.},
  author={John F. Scoggins and Scott David Ramsey},
  journal={Journal of the National Cancer Institute},
  year={2010},
  volume={102 17},
  pages={
          1371
        }
}
A recent Institute of Medicine (IOM) report (1) cited several deficiencies in the Clinical Trials Cooperative Group Program of the National Cancer Institute (NCI), including an inefficient and cumbersome oversight structure and a 20% reduction in funding since 2002. The authors concluded that these and other problems have resulted in start-up times for phase III Cooperative Group trials that range from 1.25 to almost 7 years and a clinical trial completion rate of only 50%. They also noted that… CONTINUE READING

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 48 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 13 REFERENCES

Compressing the timeline for cancer clinical trial activation

  • J. H. Doroshow, G. Hortobagyi.
  • Operational Efficiency Working Group final report…
  • 2010

CTWG evaluation plan: Results of baseline feasibility analysis

  • J. Doroshow
  • Presented at the National Cancer Advisory Board…
  • 2008
2 Excerpts

Transforming translation—harnessing discovery for patient and public benefit

  • NCI.
  • Report of the Translational Research Working…
  • 2007
1 Excerpt